ReCellTis is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Cellnovation Technology Corporation. The primary component is Bacitracin Zinc; Neomycin Sulfate; Polymyxin B Sulfate; Lidocaine.
Product ID | 71929-069_67f1c6b1-28a3-2b14-e053-2991aa0a656c |
NDC | 71929-069 |
Product Type | Human Otc Drug |
Proprietary Name | ReCellTis |
Generic Name | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, Lidocaine Hcl |
Dosage Form | Cream |
Route of Administration | TOPICAL |
Marketing Start Date | 2018-03-21 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part333B |
Labeler Name | CellNovation Technology Corporation |
Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; LIDOCAINE |
Active Ingredient Strength | 400 [USP'U]/g; mg/g; [USP'U]/g; mg/g |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2018-03-21 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part333B |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2018-03-21 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
BACITRACIN ZINC | 400 [USP'U]/g |
SPL SET ID: | 67f1c6b1-28a2-2b14-e053-2991aa0a656c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
71929-069 | ReCellTis | bacitracin zinc, neomycin sulfate, polymyxin b sulfate, lidocaine HCl |
71929-070 | ReCellTis | bacitracin zinc, neomycin sulfate, polymyxin b sulfate, lidocaine HCl |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RECELLTIS 90364383 not registered Live/Pending |
CellNovation Technology Corporation 2020-12-07 |
RECELLTIS 87562289 not registered Dead/Abandoned |
MRI Enterprises, LLC 2017-08-09 |